May 2, 2018 — Conavi Medical Inc. has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its ...
Select adult patients born with a single functioning ventricle, and who have undergone a surgical operation called the ‘Fontan procedure’ during childhood, are being enrolled in a new global-first clinical trial. The trial, led by a multi-disciplinary team of heart and lung physicians, will examine the effects of a portable, non-invasive medical device never before tested on patients with this cardiac condition.
May 2, 2018 – The Board of Directors of the Radiological Society of North America (RSNA) announced that Charles E. Kahn ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
This is a 360 degree view inside the back of the Northwestern Medicine Central DuPage Hospital Mobile Stroke Unit ...
James K. Min, M.D., FSCCT, has been selected for a five-year term as the new editor-in-chief of the Journal of Cardiovascular Computed Tomography (JCCT). He in turn has named Todd C. Villines, M.D., FSCCT, as executive editor along with Gudrun Feuchtner, M.D.
Cerebrovascular imaging analysis company iSchemaView received final clearance from the U.S. Food and Drug Administration (FDA) for Rapid CTA, the company’s 3-D imaging solution for computed tomography angiography. Rapid CTA is the newest addition to iSchemaView’s neuroimaging platform — including Rapid CTP and Rapid MRI — which is designed to provide physicians with fast, fully-automated and easy-to-interpret imaging that facilitates clinical decision making around cerebrovascular disease, such as stroke.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Edwards Lifesciences Corp.announced that it received CE Mark for the Edwards Cardioband Tricuspid Valve Reconstruction System for the treatment of tricuspid regurgitation. The Cardioband Tricuspid System is the first commercially available transcatheter therapy for the treatment of tricuspid heart valve disease.
Here is the list of the most popular articles and videos on the Diagnostic and Interventional Cardiology (DAIC) magazine ...
April 30, 2018 — LivaNova announced it completed the sale of its cardiac rhythm management (CRM) business to MicroPort ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
Mandatory public reporting of coronary artery bypass grafting (CABG) results in Massachusetts was associated with better patient outcomes compared to national findings, according to a recent study. Results of the 13-year Massachusetts experience were presented in a plenary session of the American Association for Thoracic Surgery’s 98th Annual Meeting.
The introduction of thermal ablation revolutionized the treatment of varicose veins, yet recurrence remains a stubborn ...
The acquisition of biomedical equipment company Esaote SpA’s share capital was completed on April 19, the company recently announced, by a consortium of leading Chinese investors. The consortium is composed of major companies in the medical and healthcare technology sectors, as well as investment funds with significant experience in this field.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Point of Care Decision Support (PCDS) announced the release of a new version 2.0 of their anticoagulation clinical decision support (CDS) software. The application was developed with leading clinical thrombosis experts to specifically address the new and complex challenges of managing both warfarin and non-vitamin K antagonist oral anticoagulants (NOACs). It enables healthcare provider teams to deliver consistent, measurable and evidence-based quality of care for patients on anticoagulants.
ITN Associate Editor Jeff Zagoudis explores how the mobile stroke unit (MSU) program at Northwestern Medicine Central ...
Physio-Control, now part of Stryker, announced its newest version of the LUCAS 3 Chest Compression System, version 3.1. The latest version provides new capabilities for tailored device functionality, wireless reporting and device status notifications sent over email.